(Q43248768)

17 November 2017

title

Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study (English)

1 reference

17 November 2017

1 reference

Dan-Dominic Ionescu

1

1 reference

17 November 2017

PREFER Investigators

series ordinal

2

1 reference

17 November 2017

publication date

1 January 2009

1 reference

Clinical Drug Investigation

17 November 2017

published in

1 reference

17 November 2017

volume

29

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

767-776

1 reference

Transitioning from 16-slice to 64-slice multidetector computed tomography for the assessment of coronary artery disease: are we really making progress?

17 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11319700-000000000-00000

Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy: a large US community trial.

21 January 2018

1 reference

12 December 2020

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study

1 reference

12 December 2020

[Prestarium in patients with arterial hypertension and ischemic heart disease (or risk factors) -- safe achievement of target blood pressure level (the PREMIERA study)]

1 reference

12 December 2020

Continued Improvement in Hypertension Management in England

1 reference

12 December 2020

Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study

1 reference

12 December 2020

Blood-pressure control in the hypertensive population

1 reference

12 December 2020

ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

12 December 2020

Antihypertensive utility of perindopril in a large, general practice-based clinical trial.

1 reference

12 December 2020

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy

1 reference

12 December 2020

1 reference

12 December 2020

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

1 reference

12 December 2020

ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

1 reference

12 December 2020

Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril

1 reference

12 December 2020

Comparative efficacy of perindopril and enalapril once daily using 24-hour ambulatory blood pressure monitoring

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Specific properties and effect of perindopril in controlling the renin-angiotensin system

1 reference

12 December 2020

Treatment of essential hypertension in general practice: an open-label study of 47,351 French hypertensive patients treated for one year with perindopril

1 reference

12 December 2020

10.2165/11319700-000000000-00000

Identifiers

DOI

1 reference

17 November 2017

1 reference